16:35:08 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-22 Kvartalsrapport 2024-Q3
2024-07-16 Kvartalsrapport 2024-Q2
2024-05-08 Ordinarie utdelning PROB 1.30 SEK
2024-05-07 Årsstämma 2024
2024-04-23 Kvartalsrapport 2024-Q1
2024-01-26 Bokslutskommuniké 2023
2023-10-24 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-05-05 Ordinarie utdelning PROB 1.30 SEK
2023-05-04 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-01-27 Bokslutskommuniké 2022
2022-10-21 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning PROB 1.30 SEK
2022-05-05 Årsstämma 2022
2022-04-26 Kvartalsrapport 2022-Q1
2022-02-02 Bokslutskommuniké 2021
2021-10-22 Kvartalsrapport 2021-Q3
2021-07-26 Kvartalsrapport 2021-Q2
2021-05-10 Ordinarie utdelning PROB 1.10 SEK
2021-05-07 Årsstämma 2021
2021-04-23 Kvartalsrapport 2021-Q1
2021-02-09 Bokslutskommuniké 2020
2020-10-21 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-14 Ordinarie utdelning PROB 1.00 SEK
2020-05-13 Årsstämma 2020
2020-04-24 Kvartalsrapport 2020-Q1
2020-02-11 Bokslutskommuniké 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-07-19 Kvartalsrapport 2019-Q2
2019-05-08 Ordinarie utdelning PROB 0.00 SEK
2019-05-07 Årsstämma 2019
2019-04-29 Kvartalsrapport 2019-Q1
2019-02-13 Bokslutskommuniké 2018
2018-11-06 Kvartalsrapport 2018-Q3
2018-08-13 Kvartalsrapport 2018-Q2
2018-05-03 Ordinarie utdelning PROB 0.00 SEK
2018-05-02 Årsstämma 2018
2018-05-02 Kvartalsrapport 2018-Q1
2018-01-25 Bokslutskommuniké 2017
2017-10-25 Kvartalsrapport 2017-Q3
2017-07-19 Kvartalsrapport 2017-Q2
2017-05-05 Ordinarie utdelning PROB 1.00 SEK
2017-05-04 Kvartalsrapport 2017-Q1
2017-01-24 Bokslutskommuniké 2016
2016-10-18 Kvartalsrapport 2016-Q3
2016-07-15 Kvartalsrapport 2016-Q2
2016-06-29 Extra Bolagsstämma 2016
2016-04-28 Ordinarie utdelning PROB 1.00 SEK
2016-04-27 Årsstämma 2016
2016-04-27 Kvartalsrapport 2016-Q1
2016-01-26 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-07-16 Kvartalsrapport 2015-Q2
2015-04-24 Ordinarie utdelning PROB 0.85 SEK
2015-04-23 Årsstämma 2015
2015-04-23 Kvartalsrapport 2015-Q1
2015-01-28 Bokslutskommuniké 2014
2014-10-29 Analytiker möte 2014
2014-10-29 Kvartalsrapport 2014-Q3
2014-08-19 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning PROB 0.75 SEK
2014-04-29 Kvartalsrapport 2014-Q1
2014-04-29 Årsstämma 2014
2014-01-23 Bokslutskommuniké 2013
2013-10-22 Kvartalsrapport 2013-Q3
2013-08-20 Kvartalsrapport 2013-Q2
2013-04-25 Ordinarie utdelning PROB 0.75 SEK
2013-04-24 Årsstämma 2013
2013-04-24 Kvartalsrapport 2013-Q1
2013-01-24 Bokslutskommuniké 2012
2012-10-18 Kvartalsrapport 2012-Q3
2012-09-28 Kapitalmarknadsdag 2012
2012-08-16 Kvartalsrapport 2012-Q2
2012-04-26 Årsstämma 2012
2012-04-26 Kvartalsrapport 2012-Q1
2012-01-25 Bokslutskommuniké 2011
2011-10-19 Kvartalsrapport 2011-Q3
2011-07-19 Kvartalsrapport 2011-Q2
2011-04-29 Ordinarie utdelning PROB 0.50 SEK
2011-04-29 Bonusutdelning PROB 0.5
2011-04-28 Årsstämma 2011
2011-04-28 Kvartalsrapport 2011-Q1
2011-01-26 Bokslutskommuniké 2010
2010-10-20 Kvartalsrapport 2010-Q3
2010-07-20 Kvartalsrapport 2010-Q2
2010-04-23 Ordinarie utdelning PROB 0.50 SEK
2010-04-22 Årsstämma 2010
2010-04-22 Kvartalsrapport 2010-Q1
2010-01-27 Bokslutskommuniké 2009
2009-10-21 Kvartalsrapport 2009-Q3
2009-08-18 Kvartalsrapport 2009-Q2
2009-05-07 Ordinarie utdelning PROB 0.00 SEK
2009-05-06 Årsstämma 1
2009-04-22 Kvartalsrapport 2009-Q1

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Probi är verksamt inom bioteknik. Bolaget är särskilt inriktade mot forskning och utveckling av probiotika, en god bakterie som återfinns i människans tarmsystem. Forskningsområdena inom bolaget innefattar mag och tarm, immunförsvar, metabola syndrom samt stress och återhämtning. Bland bolagets kunder återfinns större företagskunder inom livsmedelsindustrin. Bolaget grundades under 1991 och har sitt huvudkontor i Lund.
2021-06-15 10:00:00

Two Swedish companies are teaming up in a partnership with focus on the Swedish heritage of innovation, natural ingredients and high-quality products. The probiotic supplier, Probi[®] and Oriflame have entered into agreement of a global launch of a probiotic supplement within general gut health.

The product contains a scientifically proven probiotic strain with documented health effects and is a customer specific formulation, based on Probi's concept called Probi Digestis[®].

Hrvoje Rein, Global Senior Brand Manager of Wellness by Oriflame says: "We are excited to be working with Probi, which is a true innovative probiotic supplier. A fruitful collaboration has made it possible to develop the first probiotic supplement in our product range, and our interactions have turned into an important partnership."

"Wellness is one of Oriflame's strategic product categories that has generated the greatest value creation during the last years, from 8% sales in 2016 to 17% in 2020. With an extensive launch plan of our new probiotic supplement, we expect the Wellness category to grow even further," Rein concludes.

Oriflame's extensive go-to-market plan covers a number of countries, with a wide geographic reach. First launch is planned to take place in Fall 2021 with a continued roll-out in the Wellness by Oriflame markets during 2022 and onwards.

"The partnership between Probi and Oriflame is an important step in our commercial efforts in offering clinically documented probiotic products to consumers all over the world. In our partnership with Oriflame we feel commitment and alignment in offering high quality products based upon research, clinical documentation and performance," says Tom Rönnlund, CEO at Probi.

For further information, please contact:

Tom Rönnlund, CEO, Probi[®],
Phone: +46 46 286 89 40, E-mail: trd@probi.com

Charlotte Beyerholm, Director Marketing & Global Communication, Probi[®],
Phone: +46 76 870 94 65, E-mail: charlotte.beyerholm@probi.com

 

ABOUT PROBI

Probi[®] is a global company focused exclusively on researching, manufacturing, and delivering probiotics for
supplements and functional food. We are experts at managing stable, live bacteria from R&D through every
stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics
available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical
documentation. Since our founding in 1991 at Sweden's Lund University, Probi has expanded its operations to
more than 40 markets. We hold more than 400 patents globally. Read more at www.probi.com.

Probi[®] is a registered trademark of Probi AB.

 

ABOUT ORIFLAME

Oriflame, founded in 1967, is a social selling beauty company in over 60 markets, with a diverse portfolio of Swedish, nature-inspired, innovative beauty and wellness products sold and marketed through approximately 3 million Oriflame Brand Partners.